xCures Opens Artificial Intelligence xINFORM Platform Early to Inform Cancer Patient Care

June 4, 2021

xCures has announced early access for its xINFORM platform. The free platform is designed to identify personalized treatments for late-stage cancer patients. These patients have a very low 5-year survival rate below 50%. The platform uses artificial intelligence to curate patient-specific data.

“Through xINFORM, xCures helps patients find options that include combinations of existing therapeutic approaches and investigational therapies. xINFORM delivers knowledge on access mechanisms such as rationales for the use of medications in new indications, clinical trials, and expanded access (compassionate use) that empowers patients and their doctors to pursue the options they choose efficiently.” Read more here.

(Source: xCures, 6/1/21)

Share This Story!